Frontlight ResearchEarly access
Trial site
Messino Cancer Center
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Epizyme, Inc.1 trial
- Hutchmed1 trial
- Incyte Corporation1 trial
- Ipsen1 trial
- Loxo Oncology, Inc.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Melanoma1 recruiting
- Prostate cancer1 recruiting
Closed trials
Withdrawn
Terminated
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026